June 21, 2017
Mr. Glenn Batchelder is Chairman of the Board for RESET Therapeutics and XyloCor Therapeutics. Mr. Batchelder was Co-Founder and CEO of Civitas Therapeutics, a development stage pulmonary delivery therapeutic company based on the ARCUS technology platform that was sold to Accorda Therapeutics. Prior to Civitas he also served as CEO of BIND Biosciences (sold to Pfizer), CEO of Acceleron Pharma (NASDAQ: XLRN) and SVP of Operations at Millennium Pharmaceuticals (sold to Takeda). During his more than 30 years of executive leadership experience he also served in functional roles including sales, marketing, business development, manufacturing, supply chain management and R&D. He also serves on the non-profit board of directors for the Michael J. Fox Foundation for Parkinson’s Research and The Possible Project. He is the former Chairman of the MassBio board.